Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editor's Choice - Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) Prospective Cohort Study and the Generalisability of the BASIL-2 Randomised Controlled Trial.
Popplewell MA, Meecham L, Davies HOB, Kelly L, Ellis T, Bate GR, Moakes CA, Bradbury AW. Popplewell MA, et al. Among authors: moakes ca. Eur J Vasc Endovasc Surg. 2024 Jan;67(1):146-152. doi: 10.1016/j.ejvs.2023.09.041. Epub 2023 Sep 30. Eur J Vasc Endovasc Surg. 2024. PMID: 37778500 Free article.
Gefitinib and methotrexate to resolve tubal ectopic pregnancy: the GEM3 RCT.
Moakes CA, Tong S, Middleton LJ, Duncan WC, Mol BW, Whitaker LHR, Jurkovic D, Coomarasamy A, Nunes N, Holland T, Clarke F, Sutherland LC, Doust AM, Daniels JP, Horne AW. Moakes CA, et al. Southampton (UK): National Institute for Health and Care Research; 2023 Jun. Southampton (UK): National Institute for Health and Care Research; 2023 Jun. PMID: 37459432 Free Books & Documents. Review.
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.
Bradbury AW, Moakes CA, Popplewell M, Meecham L, Bate GR, Kelly L, Chetter I, Diamantopoulos A, Ganeshan A, Hall J, Hobbs S, Houlind K, Jarrett H, Lockyer S, Malmstedt J, Patel JV, Patel S, Rashid ST, Saratzis A, Slinn G, Scott DJA, Zayed H, Deeks JJ; BASIL-2 Investigators. Bradbury AW, et al. Among authors: moakes ca. Lancet. 2023 May 27;401(10390):1798-1809. doi: 10.1016/S0140-6736(23)00462-2. Epub 2023 Apr 25. Lancet. 2023. PMID: 37116524 Free article. Clinical Trial.
Snacktivity™ to promote physical activity and reduce future risk of disease in the population: protocol for a feasibility randomised controlled trial and nested qualitative study.
Daley AJ, Griffin RA, Moakes CA, Sanders JP, Skrybant M, Ives N, Maylor B, Greenfield SM, Gokal K, Parretti HM, Biddle SJH, Greaves C, Maddison R, Mutrie N, Esliger DW, Sherar L, Edwardson CL, Yates T, Frew E, Tearne S, Jolly K. Daley AJ, et al. Among authors: moakes ca. Pilot Feasibility Stud. 2023 Mar 17;9(1):45. doi: 10.1186/s40814-023-01272-8. Pilot Feasibility Stud. 2023. PMID: 36932423 Free PMC article.
Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial.
Horne AW, Tong S, Moakes CA, Middleton LJ, Duncan WC, Mol BW, Whitaker LHR, Jurkovic D, Coomarasamy A, Nunes N, Holland T, Clarke F, Doust AM, Daniels JP; GEM3 collaborative. Horne AW, et al. Among authors: moakes ca. Lancet. 2023 Feb 25;401(10377):655-663. doi: 10.1016/S0140-6736(22)02478-3. Epub 2023 Feb 1. Lancet. 2023. PMID: 36738759 Free article. Clinical Trial.
Monofilament suture versus braided suture thread to improve pregnancy outcomes after vaginal cervical cerclage (C-STICH): a pragmatic randomised, controlled, phase 3, superiority trial.
Hodgetts Morton V, Toozs-Hobson P, Moakes CA, Middleton L, Daniels J, Simpson NAB, Shennan A, Israfil-Bayli F, Ewer AK, Gray J, Slack M, Norman JE, Lees C, Tryposkiadis K, Hughes M, Brocklehurst P, Morris RK. Hodgetts Morton V, et al. Among authors: moakes ca. Lancet. 2022 Oct 22;400(10361):1426-1436. doi: 10.1016/S0140-6736(22)01808-6. Lancet. 2022. PMID: 36273481 Free article. Clinical Trial.
WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial - adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic.
Magee LA, Tohill S, Kirkham K, Evans R, Gkini E, Moakes CA, Stubbs C, Thornton J, von Dadelszen P; WILL Trial Study Group. Magee LA, et al. Among authors: moakes ca. Trials. 2022 Oct 21;23(1):884. doi: 10.1186/s13063-022-06834-4. Trials. 2022. PMID: 36271441 Free PMC article. Clinical Trial.
11 results